Article
Long-term impact of fecal transplantation in healthy volunteers
2019-06-14
Abstract excerpt
<h4>Background</h4> Fecal microbiota transplantation (FMT) is now approved for the treatment of refractory recurrent clostridial colitis, but a number of studies are ongoing in inflammatory bowel diseases, i.e., Crohn’s disease, nonspecific ulcerative colitis, and in other autoimmune conditions. In most cases, the effects of FMT are evaluated on patients with initially altered microbiota. The aim of the present s...
Topics
Open a Topic to create a Post that cites this publication.
- Bacteriophages and microbial interactions
- Clostridium difficile and Clostridium perfringens research
- Gastrointestinal motility and disorders
- Gut microbiota and health
- Helicobacter pylori-related gastroenterology studies
- Microscopic Colitis
- Probiotics and Fermented Foods
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 29208a73-c90b-553b-a93a-44677dead98b
- DOI
- 10.1101/671644
